Replies to post #318667 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

The baby bird was flapping alot but was but a fledgling. The parents are now taking away the best.

Time to fly!
or
Fall.

wook

[bigbro1]

Criminals can't even get the article right. Shareholders money in the drain !

The firm is now looking to license to sell the candidate (along with the rest of its pipeline), a decision triggered by negative Phase III trial results announced in February this year.

Its failed in 2016 not this year.

Peregrine's lead candidate is bavituximab, a chimeric monoclonal antibody (mAb) under US Food and Drug Administration (FDA) fast-track designation for the treatment of second-line non-small cell lung cancer (NSCLC).

FTD is meaningless anymore since Sunrise failed.

Who are you kidding ? lets see who buys the failed drug from these criminals.